#12 Alpha Score 99.4

Jeong Hee-seok

Private Banker, Hana Securities Centerfield W
· tracked since Jan 2026
12
BUZZBERG The leaderboard is ranked by Alpha Score, which weighs a speaker's average return and number of evaluated calls. Small samples are adjusted toward the platform average. Credibility does not affect the score. Read the FAQ
Alpha Score 99.4
Calls
14
Win Rate
92.9%
return
+66.4%
Calls 14 4 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 0
Win Rate 93% Long 14 Short 0
Win Rate
7d 86%
30d 86%
90d 71%
Average Return +66.4% Long Return +66.4% Short Return -
Average Return
7d +4.7%
30d +15.3%
90d +22.1%
Visual Insights Log in to see more
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 12
$123.93
+27.5%
Pharma R&D recovery lifts Korean biotech.
The global pharma R&D recovery visible through IQVIA's order rebound should also lift Korean biotech companies with good pipelines, because big pharma is again spending on licensing and overseas IP.
Thematic ETFs
Long
Jan 12
$51.76
-17.1%
US nuclear stocks attract AI power flows.
In the US, capital is rotating into nuclear/power stocks that announce new contracts or capacity expansion because AI remains power-constrained; this flow should support US nuclear power names.
Thematic ETFs
Long
Jan 12
$1081.00
+6.6%
Eli Lilly leads obesity treatment volume
Eli Lilly is his preferred large US biotech because the obesity-treatment market is entering a volume-growth phase and Lilly should be a key beneficiary.
GLP-1 / Obesity
Showing 3 of 14 calls · sorted by mentions

Jeong Hee-seok has 14 trade ideas tracked on Buzzberg across 14 tickers since January 2026. Ranked #12 on the Buzzberg Alpha leaderboard. Most covered: 000660.KS, 005930.KS, AI-SECTOR.

Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology